Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Real-World, Digital-First GLP-1 Receptor Agonist Treatment for Women

  • By

  • John Deanfield

  • Jamie Lai Chun Wong

  • Michail Katsoulis

  • Emma Deanfield

  • Raj Thakkar

  • Riyaz Patel

  • Rachael Joy

  • Matthew Noble

  • Donna H. Ryan

  • October 16, 2026

Share

  • 1

    The digital-first program prescribed and dispatched GLP-1 receptor agonist therapy to 8,127 adult women recruited from a community population.

  • 2

    The remote care model included monthly questionnaires, weekly live-video check-ins, supervised weight and medication verification, and clinician-led dose titration.

  • 3

    Participants were aged 18 to 79 years, had a mean baseline weight of 104.2 kg and BMI of 38.2, and 95.5% had obesity.

  • 4

    At 6 months, 7,297 participants (89.8%) provided weight measurements and 6,466 (79.6%) completed repeat biochemical assessment.

  • 5

    The study examined treatment response by age, starting weight, socioeconomic position, and ethnicity in a large real-world cohort of women.

Original Source(s)

Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women

  • by John Deanfield, Jamie Lai Chun Wong, Michail Katsoulis, Emma Deanfield, Raj Thakkar, Riyaz Patel, Rachael Joy, Matthew Noble, Donna H. Ryan

  • October 16, 2026

Related Content

Mild metabolic profile may mask MASLD risk

Five reproducible MASLD subtypes showed distinct genetic profiles and patterns of metabolic comorbidity and disease progression.

NNS beverages may match water in weight control

Adults assigned to nonnutritive sweetened beverages or water maintained weight reductions through 104 weeks, with no statistically significant difference between groups.

10 states that support physician work-life balance

These 10 states have paid family or medical leave programs and health, wellness, peer support, or monitoring resources available to physicians or other health professionals.